Mauro Ferrari

Mauro Ferrari is a distinguished Professor in the Department of Pharmaceutics at the University of Washington, joining in 2019. Previously, he served as tenured professor in engineering and/or medicine at institutions including the University of Texas, University of California Berkeley, Ohio State University, and Weill Cornell Medicine. He led the Houston Methodist Research Institute as President & CEO and held leadership roles at the European Research Council.

• Dottore in Matematica, Universita di Padova, Italy
• PhD and MS in Mechanical Engineering, University of California, Berkeley
• Executive education at Harvard Business School and Wharton

As a pioneer of nanomedicine and transport oncophysics, his research focuses on cancer therapeutics, nanomedicine, drug delivery technology, mathematical oncology, and biological mass transport. His laboratory leads a DOD-funded initiative for metastatic breast cancer cures.

His selected publications highlight trends in nanoparticle design, molecular transport, cancer nanotherapy, and multistage delivery systems.

Scientific leadership includes clinical translation of dozens of drugs and medical devices. Current entrepreneurial roles: CEO of DXT Pharmaceuticals, Director at Arrowhead Pharmaceuticals, and Scientific Founder of BrYet US.